Booger Bacteria’s Sweet Immune Suppression

Sweet taste receptor-activating molecules produced by sinus microbes suppress the local innate immune system in humans.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, LHOONStaphylococcus bacteria from people’s noses produce amino acids that curb secretions of antimicrobial proteins in the sinus, according to a report published yesterday (September 5) in Science Signaling. The amino acids activate sweet taste receptors present on sinus cells, suggesting that pharmaceutical inhibition of these receptors may have the potential to treat sinus infections.

“This work expands upon a direction of research involving taste receptors and identifies mechanisms by which Staphylococcus bacteria modulate host immunity via interactions with these receptors,” says Martin Desrosiers of the University of Montreal who was not involved with the project. “It also helps explain how bacteria can contribute to the development and persistence of chronic rhinosinusitis,” he adds.

Taste receptors are only called taste receptors because they were first discovered on tongue cells, explains Robert Lee of the University of Pennsylvania Perelman School of Medicine in Philadelphia. But in fact, he says, “they are just chemosensors,” and are found in many different parts of the body, such as the kidney, pancreas, brain, and sinus. “We only know the tip of the iceberg of what ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies